L-Valyl-L-glutaminyl-L-isoleucyl-L-valyl-L-tyrosyl-L-lysine is a hexapeptide combining hydrophobic, polar, aromatic, and basic residues. The sequence forms a versatile motif for studying early folding and ligand-recognition surfaces. Researchers explore hydrogen-bond patterns, amphipathic behavior, and protease susceptibility. Applications include motif discovery, peptide-receptor modeling, and sequence-activity correlation.
CAT No: R2604
CAS No:329897-62-3
Synonyms/Alias:L-Valyl-L-glutaminyl-L-isoleucyl-L-valyl-L-tyrosyl-L-lysine;PHF6;329897-62-3;L-Valyl-L-glutaminyl-L-isoleucyl-L-valyl-L-tyrosyl-L-lysine;Hexapeptide PHF6;Val-Gln-Ile-Val-Tyr-Lys-OH;DTXSID70580041;GLXC-26489;HY-P4808;(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-5-amino-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]hexanoic acid;CS-0674591;
L-Valyl-L-glutaminyl-L-isoleucyl-L-valyl-L-tyrosyl-L-lysine, also known as VQIVYK peptide, is a synthetic hexapeptide sequence that has garnered significant attention in the field of biochemical and molecular research. Characterized by its unique arrangement of amino acids, this peptide is derived from the microtubule-associated protein tau and is known for its propensity to self-assemble into fibrillar structures under specific experimental conditions. Its sequence is particularly notable for promoting intermolecular interactions, making it a valuable tool for studying protein aggregation phenomena. The molecular features of VQIVYK, including its hydrophobic and polar amino acid residues, facilitate its use in a variety of research contexts where precise modeling of protein misfolding and aggregation is required.
Protein Aggregation Studies: L-Valyl-L-glutaminyl-L-isoleucyl-L-valyl-L-tyrosyl-L-lysine is widely employed as a model peptide in the investigation of protein aggregation mechanisms, particularly those related to neurodegenerative disorders. Researchers utilize this hexapeptide to mimic the core aggregation-prone motifs found in tau proteins, enabling detailed analysis of the physicochemical factors that drive fibril formation. By observing the self-assembly behavior of VQIVYK under controlled laboratory conditions, scientists can elucidate the nucleation and elongation phases of amyloid fibril development and examine the influence of environmental variables such as pH, temperature, and ionic strength on aggregation kinetics. These studies provide foundational insights into the molecular underpinnings of pathological protein aggregation.
Structural Biology Research: The VQIVYK motif serves as an essential experimental system for structural biology investigations aimed at unraveling the atomic-level details of amyloid fibril architecture. Advanced techniques such as nuclear magnetic resonance (NMR) spectroscopy, cryo-electron microscopy (cryo-EM), and X-ray crystallography are frequently employed to characterize the conformational states and intermolecular interactions of this peptide. By leveraging the well-defined aggregation behavior of the hexapeptide, researchers can generate high-resolution structural models that reveal the arrangement of β-sheet-rich fibrillar assemblies. These efforts contribute to a deeper understanding of the structural diversity and stability of amyloid aggregates, informing the design of molecules capable of modulating or inhibiting pathological aggregation.
Drug Discovery and Screening: VQIVYK is instrumental in the development and evaluation of aggregation inhibitors and modulators for therapeutic research. High-throughput screening assays often incorporate this peptide as a substrate to assess the efficacy of small molecules, peptides, or antibodies in preventing or disrupting fibril formation. The reproducible aggregation kinetics of the hexapeptide make it an ideal candidate for quantitative studies, enabling the identification of lead compounds with potential anti-aggregation activity. Insights gained from such screening efforts support the rational design of therapeutic agents targeting protein misfolding disorders at the molecular level.
Biomaterials and Nanotechnology: The self-assembling properties of L-Valyl-L-glutaminyl-L-isoleucyl-L-valyl-L-tyrosyl-L-lysine have inspired innovative applications in biomaterials science and nanotechnology. Researchers exploit the peptide's ability to form ordered nanostructures, such as fibrils and hydrogels, to develop novel biomimetic materials with tunable mechanical and chemical properties. These materials can serve as scaffolds for tissue engineering, templates for nanowire formation, or platforms for the immobilization of bioactive molecules. The versatility of the hexapeptide in constructing hierarchical structures underlies its value in creating functional materials for diverse technological applications.
Biophysical Method Development: The distinctive aggregation behavior of VQIVYK has made it a reference system for the development and optimization of biophysical methods used to monitor protein assembly. Spectroscopic techniques such as circular dichroism (CD), fluorescence spectroscopy, and atomic force microscopy (AFM) are routinely validated using this peptide to ensure sensitivity and reproducibility in detecting conformational changes and aggregate formation. By serving as a benchmark for method calibration, the hexapeptide enables researchers to refine analytical protocols and enhance the accuracy of aggregation studies across a wide range of protein systems.
1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.